Daneyal Farouq

Scientist I GACT at CRISPR Therapeutics

Role: Scientist i at CRISPR Therapeutics
Location: Boston, MA, US
LinkedIn followers: 500 followers

ScienceView LinkedIn profile

Experience

Scientist i
CRISPR Therapeutics
Jan 2023 — Present · Boston, MA, US

Education

University of Massachusetts Amherst
Bachelor of Science (BS), Biology
2010 — 2014

Skills

Program Management
Leadership
Grant Writing
Statistics
Rt-Pcr
Molecular Cloning
Plant Tissue Culture
Research
Restriction Mapping
Dna Extraction
Pcr Primer Design
Rna Quantification
Reverse Transcription
Cell Culture
Dna Quantification
Public Speaking
Agarose Gel Electrophoresis
Pcr
Teamwork
Perl
Chemistry

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
•••••@crisprtx.com
Personal email
•••••@•••••.com
Direct dial
+•• ••• ••• ••••

Unlock verified contacts

Free to start · No credit card required

Current company

CRISPR Therapeutics

Biotechnology Research · 343 employees · Founded 2013 · Boston, Massachusetts, United States

Since its inception over a decade ago, CRISPR Therapeutics has evolved from a research-stage company advancing gene editing programs into a leader that celebrated the historic approval of the first-ever CRISPR-based therapy. The Company has a diverse portfolio of product candidates across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, cardiovascular, autoimmune, and rare diseases. In 2018, CRISPR Therapeutics advanced the first-ever CRISPR/Cas9 gene-edited therapy into the clinic to investigate the treatment of sickle cell disease and transfusion-dependent beta thalassemia. Beginning in late 2023, CASGEVY® (exagamglogene autotemcel [exa-cel]) was approved in several countries to treat eligible patients with either of these conditions. The Nobel Prize-winning CRISPR technology has revolutionized biomedical research and represents a powerful, clinically validated approach with the potential to create a new class of potentially transformative medicines. To accelerate and expand its efforts, CRISPR Therapeutics has formed strategic partnerships with leading companies including Vertex Pharmaceuticals. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations based in Boston, Massachusetts and San Francisco, California.

crisprtx.com

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Experience

Scientist i

Education

University of Massachusetts Amherst

Skills

Find verified contacts for anyone on LinkedIn